From: Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma
Characteristic | Value |
---|---|
Total (n) | 20 |
Average age (years) | 51.5 (range 24–82) |
Gender (n) | Â |
 Male | 16 |
 Female | 4 |
Mean cochlea volume (cm3) | Â |
 Left cochlea | 0.215 (range 0.09–0.54) |
 Right cochlea | 0.221 (range 0.08–0.45) |
Mean prescription dose (Gy) | 69.78 (range 66–70) |
Concurrent chemotherapy (n) | Â |
 Cisplatin | 12 |
 Carboplatin (+ taxol/5-FU) | 5 |
 None | 3 |
Performance status before RT start (n) | Â |
 ECOG 0 | 12 |
 ECOG 1 | 6 |
 ECOG 2 | 2 |
T status (n) | Â |
 T1 | 4 |
 T2 | 8 |
 T3 | 2 |
 T4 | 6 |
N status (n) | Â |
 N0 | 10 |
 N1 | 3 |
 N2 | 5 |
 N3 | 2 |
M status (n) | Â |
 M0 | 19 |
 M1 | 1 |